PPAR Signaling Pathway in Diabetic Cardiomyopathy

An in vitro lipotoxicity model with MCMs & the molecular mechanism of the PPAR signaling on mitochondrial energy metabolism disorder & cellular injury in DCM.

Related Keywords

China ,Germany ,Japan ,Chongqing ,United States ,Kyoto ,United Kingdom ,Xiaoqiu Xiao ,Beyotime Biotechnology Co ,Bc Oil ,Sigma Co ,Santa Cruz Biotechnology Co ,Mcms Beyotime Biotechnology Co ,Cell Signaling Technology Co ,Advansta Co ,Bopei Biotechnology Co ,Merckmillipore Co ,Abclonal Biotechnology Co ,Abmart Biotechnology Co ,Blank Group ,Detection Kit Beyotime Biotechnology Co ,Fbs Co ,International Diabetes Federation ,Abcam Co ,Blank Group Od Control ,Cellular Oil Red ,National Institutes Of Health ,Dna Synthesis Kit Accurate Biotechnology Co ,Takara Biotechnology Co ,First Affiliated Hospital Of Chongqing Medical University ,Medchemexpress Co ,Solarbio Biotechnology Co ,Olympus Co ,Genetex Co ,Proteintech Group Co ,Thermo Fisher Scientific Co ,Pathway Enrichment ,First Affiliated Hospital ,Chongqing Medical University ,Treated Group ,Control Group ,National Institutes ,Morphological Changes ,Low Viability ,Severe Lipid Accumulation ,